$PCRX 3 SEC Filings

Filed On	Filing
12 Jun 2026	Form 3: Wiggans Thomas G, Director No securities owned
29 Jan 2026	Form 3: Hirawat Samit, Director No securities owned
28 Jan 2025	Form 3: Teehan Brendan, Chief Commercial Officer No securities owned
23 Oct 2024	Form 3: Cross Shawn, Chief Financial Officer No securities owned
04 Jan 2024	Form 3: Lee Frank D., Director No securities owned
07 Dec 2023	Form 3: Slonin Jonathan, Chief Medical Officer Holds 45,884.94 shares of Common Stock
11 Oct 2023	Form 3: Young Alethia, Director No securities owned
11 Oct 2023	Form 3: Yang Michael J., Director No securities owned
11 Oct 2023	Form 3: Ceesay Abraham, Director No securities owned
11 Oct 2023	Form 3: Bigal Marcelo, Director No securities owned
28 Mar 2023	Form 3: Ellis Ronald J. Jr., Chief Strategy Officer Holds 33,185 shares of Common Stock
11 May 2022	Form 3: Gaugler Daryl, Chief Operating Officer Holds 12,600 shares of Common Stock
17 Dec 2021	Form 3: Molloy Anthony, Chief Lgl & Compliance Officer Holds 15,550 shares of Common Stock
30 Jul 2021	Form 3: Slonin Jonathan, Chief Clinical Officer Holds 21,350 shares of Common Stock
05 May 2020	Form 3: Manning Donald C., Chief Medical Officer No securities owned
07 Nov 2019	Form 3: Ellis Ronald J. Jr., Director and 1 other · TELA Bio Inc
20 Sep 2019	Form 3: Christie Christopher, Director
19 Jun 2019	Form 3: Reinhardt Max, President No securities owned
07 Sep 2018	Form 3: McLoughlin Dennis, Chief Commercial Officer Holds 14,833 shares of Common Stock
07 Sep 2018	Form 3: Winston Roy, Chief Clinical Officer Holds 16,500 shares of Common Stock

Comments